BAFMX
Price
$18.26
Change
+$0.22 (+1.22%)
Updated
Jul 3 closing price
Net Assets
73.17M
RRMGX
Price
$89.71
Change
+$0.38 (+0.43%)
Updated
Jul 3 closing price
Net Assets
28B
Interact to see
Advertisement

BAFMX vs RRMGX

Header iconBAFMX vs RRMGX Comparison
Open Charts BAFMX vs RRMGXBanner chart's image
Brown Advisory Mid-Cap Growth Instl
Price$18.26
Change+$0.22 (+1.22%)
VolumeN/A
Net Assets73.17M
T. Rowe Price Mid-Cap Growth R
Price$89.71
Change+$0.38 (+0.43%)
VolumeN/A
Net Assets28B
BAFMX vs RRMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BAFMX vs. RRMGX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFMX is a Buy and RRMGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 28B vs. BAFMX (73.2M). BAFMX (0.00) and RRMGX (0.00) have matching dividends . BAFMX was incepted earlier than RRMGX: BAFMX (7 years) vs RRMGX (23 years). RRMGX (1.29) is less costly to investors than BAFMX (0.85). BAFMX is a more actively managed with annual turnover of: 63.00 vs. RRMGX (22.60). RRMGX has a lower initial minimum investment than BAFMX: RRMGX (2500) vs BAFMX (1000000). BAFMX annual gain was more profitable for investors over the last year : 17.81 vs. RRMGX (-2.95). BAFMX return over 5 years is better than : 30.43 vs. RRMGX (2.39).
BAFMXRRMGXBAFMX / RRMGX
Total Expense Ratio0.831.2964%
Annual Report Gross Expense Ratio0.851.2966%
Fund Existence7 years23 years-
Gain YTD8.1112.036398%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets73.2M28B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.81-2.95-603%
Returns for 3 years46.2011.65397%
Returns for 5 years30.432.391,276%
Returns for 10 yearsN/A15.34-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MODV3.250.11
+3.50%
ModivCare
GANX1.690.06
+3.36%
Gain Therapeutics
AVDL8.930.12
+1.36%
Avadel Pharmaceuticals plc
QVCGP7.830.05
+0.64%
QVC Group Inc.
WFG77.34N/A
N/A
West Fraser Timber Co Ltd